PEOPLE - Gull Laboratories makes appointment:
This article was originally published in Clinica
Executive Summary
Dr Silke Humberg has replaced Dr George Evanega as president and CEO of Gull Laboratories, a majority owned subsidiary of the German company Fresenius. No reason was given for Dr Evanega's departure from the US diagnostic test kit developer. Dr Humberg was previously with Fresenius's intensive care and haemotechnology division.